MedPath

Ultrasonographic Diameter of Optic Nerve Sheath in Fluid Assessment in Severe Preeclamptic Patients

Conditions
Severe Pre-eclampsia
Registration Number
NCT05176652
Lead Sponsor
Sohag University
Brief Summary

Changes in the optic nerve sheath diameter detected by ultrasound are considered an important manifestation of increased intracranial pressure . The normal optic nerve sheath diameter measures up to 5.0 mm and an average optic nerve sheath diameter more than 5 mm is considered abnormal and elevated intracranial pressure should be suspected.Cerebral edema have been demonstrated in 71% to 100% of magnetic resonance imaging in preeclamptic patients and an increase in optic nerve sheath diameter has been described in preeclamptic females compared to healthy pregnant females Therefore, Increased optic nerve sheath diameter can indirectly reflect the state of intracranial edema that could be a part of generalized edema of preeclampsia and it could be a possible marker of generalized tissue edema and fluid overload in these patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Systolic blood pressure of 160mm Hg or higher, or diastolic blood pressure of 110mm Hg or higher on 2 occasions at least 6 hours apart on bed rest.
  • Proteinuria ≥5g in a 24 hour urine specimen or ≥3+ on 2 random urine samples collected at least 4 hours apart.
  • patient acceptance
  • Accepted mental state of the patients
Exclusion Criteria
  • patient refusal to participate in the study
  • chronic kidney disease
  • chronic pulmonary disease
  • chronic cardiac disease
  • chronic hypertension
  • previous ocular operation and diseases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
correlation between optic nerve sheath diameter and extravascular lung waterup to 24 hours

correlation between ultrasound assessment of optic nerve sheath diameter and extravascular lung water

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hossam Eldin Hassan Ahmed Abdelghani

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath